Zajner Chris, Patil Nikhil, McInnis Rachel, Van Uum Stan, Fraser Alexander, Ohorodnyk Pavlo, Bursztyn Lulu L C D
Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
Thyroid. 2025 Jun;35(6):706-710. doi: 10.1089/thy.2024.0438. Epub 2024 Dec 20.
Extraocular muscle (EOM) enlargement occurs in both acromegaly and Graves' disease, but the degree and pattern of enlargement have not been directly compared in these patient groups. This study investigated whether acromegaly and Graves' orbitopathy (GO) are associated with different patterns of EOM enlargement at the time of diagnosis. Retrospective cohort. All new patients with a diagnosis of acromegaly or GO who presented to St Joseph's Health Care in London, Ontario, between January 1, 2015, and July 1, 2020, and who underwent computed tomography (CT) scanning with adequate orbital imaging were considered for inclusion. We included age- and sex-matched control patients with pituitary macroadenomas without thyroid or growth hormone abnormalities. Orbital CT scans were analyzed by a single neuroradiologist, who measured the maximum diameter and cross-sectional area of each EOM. The relative likelihood of involvement of each rectus EOM was analyzed separately using an analysis of variance test. We included 16 patients with GO, 17 with acromegaly, and 18 controls. Ages (mean ± standard deviation) of groups were 55.6 ± 18.0, 50.2 ± 15.7, and 49.3 ± 14.0 years. The mean maximum diameter of EOMs in GO, acromegaly, and controls was inferior rectus (IR) = 4.77 ± 1.53, 4.66 ± 0.61, and 3.68 ± 0.61 mm; medial rectus (MR) = 5.35 ± 2.23, 4.84 ± 0.81, and 3.65 ± 0.42 mm; superior rectus (SR) = 4.94 ± 1.84, 4.88 ± 0.91, and 3.68 ± 0.61 mm; and lateral rectus (LR) = 3.91 ± 1.59, 4.55 ± 0.60, and 3.20 ± 0.43 mm. The IR, MR, and SR muscles were significantly larger in the GO group compared with controls (IR, = 0.020; SR, = 0.004; MR, < 0.001; and LR, = 0.166), and all four EOMs were larger in acromegaly compared with controls (IR, = 0.039; SR, = 0.006; MR, = 0.006; and LR, = 0.001). There was no significant difference between the GO and acromegaly groups (IR, = 0.959; SR, = 0.987; MR, = 0.408; and LR, = 0.250). GO and acromegaly groups demonstrated the enlargement of the IR, MR, and SR muscles when compared with controls. The GO group did not show significantly larger EOM sizes compared with the acromegaly group. In the GO group, the IR, MR, and SR were similarly affected and did not follow previously described patterns of enlargement in GO.
在肢端肥大症和格雷夫斯病中均会出现眼外肌(EOM)增大的情况,但在这些患者群体中,增大的程度和模式尚未得到直接比较。本研究调查了肢端肥大症和格雷夫斯眼眶病(GO)在诊断时是否与不同的EOM增大模式相关。回顾性队列研究。纳入2015年1月1日至2020年7月1日期间就诊于安大略省伦敦市圣约瑟夫医疗保健中心、诊断为肢端肥大症或GO且接受了具备充分眼眶成像的计算机断层扫描(CT)的所有新患者。我们纳入了年龄和性别匹配的垂体大腺瘤对照患者,这些患者无甲状腺或生长激素异常。眼眶CT扫描由一名神经放射科医生进行分析,该医生测量了每条EOM的最大直径和横截面积。使用方差分析分别分析每条直肌EOM受累的相对可能性。我们纳入了16例GO患者、17例肢端肥大症患者和18例对照。各组年龄(均值±标准差)分别为55.6±18.0岁、50.2±15.7岁和49.3±14.0岁。GO组、肢端肥大症组和对照组EOM的平均最大直径分别为:下直肌(IR)=4.77±1.53、4.66±0.61和3.68±0.61mm;内直肌(MR)=5.35±2.23、4.84±0.81和3.65±0.42mm;上直肌(SR)=4.94±1.84、4.88±0.91和3.68±0.61mm;外直肌(LR)=3.91±1.59、4.55±0.60和3.20±0.43mm。与对照组相比,GO组的IR、MR和SR肌肉明显更大(IR,P = 0.020;SR,P = 0.004;MR,P < 0.001;LR,P = 0.166),与对照组相比,肢端肥大症组的所有四条EOM均更大(IR,P = 0.039;SR,P = 0.006;MR,P = 0.006;LR,P = 0.001)。GO组和肢端肥大症组之间无显著差异(IR,P = 0.959;SR,P = 0.987;MR,P = 0.408;LR,P = 0.250)。与对照组相比,GO组和肢端肥大症组均表现出IR、MR和SR肌肉增大。与肢端肥大症组相比,GO组未显示出EOM尺寸明显更大。在GO组中,IR、MR和SR受到类似影响,且未遵循先前描述的GO增大模式。